AB-005氮杂环庚烷异构体 | 1445751-74-5

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吲哚及其衍生物
• 中文名称: AB-005氮杂环庚烷异构体
• 英文名称: (1-(1-Methylazepan-3-yl)-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone
• 英文别名: [1-(1-methylazepan-3-yl)indol-3-yl]-(2,2,3,3-tetramethylcyclopropyl)methanone
• CAS: 1445751-74-5
• 化学式: C₂₃H₃₂N₂O
• 分子量: 352.5
• InChiKey: VNSNHIFBQMRMRE-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.7
• 重原子数：
  26
• 可旋转键数：
  3
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.61
• 拓扑面积：
  25.2
• 氢给体数：
  0
• 氢受体数：
  2

文献信息

• IMMUNOASSAY FOR CYCLOPROPYLINDOLE BASED SYNTHETIC CANNABINOIDS, METABOLITES AND DERIVATIVES THEREOF
  申请人：Randox Laboratories Limited

  公开号：US20140287441A1

  公开（公告）日：2014-09-25

  The invention relates to the detection and quantification of cyclopropylindole based synthetic cannabinoids UR-144 and XLR-11 by providing antibodies based on novel immunogens. These antibodies can be incorporated into methods and kits for the detection of UR-144, XLR-11 and their metabolites.

  该发明涉及基于新型免疫原的抗体，用于检测和定量环丙基吲哚类合成大麻素UR-144和XLR-11。这些抗体可以应用于检测UR-144、XLR-11及其代谢物的方法和试剂盒中。
• Immunoassay for cyclopropylindole based synthetic cannabinoids, metabolites and derivatives thereof
  申请人：Randox Laboratories Ltd.

  公开号：EP2781527A1

  公开（公告）日：2014-09-24

  The invention relates to the detection and quantification of cyclopropylindole based synthetic cannabinoids UR-144 and XLR-11 by providing antobodies based on novel immunogens. These antobodies can be incorporated into methods and kits for the detection of UR-144, XLR-11 and metabolites or derivatives thereof.

  本发明涉及通过提供基于新型免疫原的抗体来检测和定量环丙基吲哚类合成大麻素 UR-144 和 XLR-11。 这些抗体可纳入检测 UR-144、XLR-11 及其代谢物或衍生物的方法和试剂盒中。
• NUCLEAR MAGNETIC RESONANCE IMPLEMENTED SYNTHETIC INDOLE AND INDAZOLE CANNABINOID DETECTION, IDENTIFICATION, AND QUANTIFICATION
  申请人：HOFSTRA UNIVERSITY

  公开号：US20220026380A1

  公开（公告）日：2022-01-27

  The present invention provides a method for detecting synthetic indole and indazole cannabinoids in a sample known or suspected to contain a synthetic indole or indazole cannabinoid. A deuterated solvent is added to the solid sample, creating a suspension. The suspension is mixed to release the cannabinoid from the solid sample. The suspension is subject to a NMR spectroscopy process to produce a sample NMR spectrum. The synthetic cannabinoid is detected in the suspension by analysis of the sample NMR spectrum. When one-dimensional proton NMR is used, detection of a first peak between 8.00 and 8.50 ppm and a second peak between 4.00 and 4.40 ppm, indicates the presence of a synthetic indole or indazole cannabinoid. When two-dimensional Correlation Spectroscopy (COSY) NMR is used, detection of a first spot between 6.50 and 9.00 ppm and a second spot between 1.50 and 4.50 ppm indicates the presence of a synthetic indole or indazole cannabinoid. The method is performed in the absence of chromatography and optionally, may be used to quantify the amount of synthetic cannabinoid.
• US9079964B2
  申请人：——

  公开号：US9079964B2

  公开（公告）日：2015-07-14